Upgrade to SI Premium - Free Trial

Biogen Idec, Inc. (BIIB) Tops Q2 EPS by 37c; Issues Solid Guidance

July 25, 2013 7:09 AM
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q2 EPS of $2.30, $0.37 better than the analyst estimate of $1.93. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance Hot Earnings Hot Guidance Management Comments

Next Articles